Device / Technology News

RSS

Zalicus presents synergistic drug data at Targeted Cancer Therapies World Europe 2010 meeting

Zalicus Inc. presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the Targeted Cancer Therapies World Europe 2010 meeting in Zurich on September 23, 2010.

24 Sep 2010

ENTrigue announces first clinical experience with Ventera sinus dilation systems

ENTrigue Surgical, Inc., a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today the first clinical experience with its Ventera sinus dilation systems.

23 Sep 2010

New online health care reform resource from WebMD

WebMD Health Corp., the leading source of health information for consumers and health care professionals, is launching a new online resource to help Americans better understand the health care reform provisions that go into effect today. WebMD's health care reform resource presents a series of exclusive video interviews with Health and Human Services Secretary Kathleen Sebelius as well as in-depth editorial coverage, blogs, community and interactive polls.

23 Sep 2010

GSMA recognises mobile health in 16th Annual Global Mobile Awards programme

The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.

23 Sep 2010

Vision-Sciences, Stryker sign urology supply agreement

Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.

From Stryker 23 Sep 2010

SAHA selects TeleTracking's RadarFind as exclusive real-time locating provider

The Southern Atlantic Healthcare Alliance (SAHA) has selected TeleTracking's RadarFind as the exclusive real-time locating provider for member hospitals. SAHA, which is comprised of 16 hospitals in North Carolina, chose RadarFind's real-time location system (RTLS) to enable their members to track medical equipment, patients and staff.

23 Sep 2010

InspireMD to launch MGuard Prime MicroNet stent system at TCT Conference

InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.

23 Sep 2010

BioCision launches CryoPrep System for cell freezing procedures

BioCision LLC, the CoolPrep company, announced today that it has expanded its line of innovative benchtop sample handling tools with the launch of the CryoPrep System, a modular complete solution for cell freezing procedures.

23 Sep 2010

Teleflex launches Gibeck Humid-Flo Passive Humidification Kit for Ventilator Associated Pneumonia risk reduction

Teleflex has introduced the Gibeck Humid-Flo Passive Humidification Kit, an integrated system that promotes best practices for Ventilator Associated Pneumonia (VAP) risk reduction. This convenient kit includes everything required to initiate passive humidification for the first 72 hours of mechanical ventilation.

23 Sep 2010

Use of CYPHER stent in diabetic patients can result in significant cost savings

New analysis presented at the Transcatheter Cardiovascular Therapeutics meeting (TCT 2010) in Washington, DC, indicates that the broad use of CYPHER Sirolimus-eluting coronary stent in patients with diabetes would result in substantial cost savings, as compared to the use of everolimus-eluting stents (EES), paclitaxel-eluting stents (PES), or zotarolimus-eluting stents (ZES).

23 Sep 2010

MSPU launches Healthcare IT University

Managed Services Provider University (MSPU), the largest consultancy and online resource dedicated to business transformation and improvement strategies for information technology (IT) professionals and managed services providers worldwide, announced today the launch of Healthcare IT University - a new Healthcare IT-focused website at www.hitu.us, and the concurrent release of its inaugural 2-volume publication titled The Guide to a Successful Healthcare IT Practice.

23 Sep 2010

TRSi launches new courses in healthcare documentation

TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.

23 Sep 2010

Golden Helix refactors HSPH's software for studying disease heritability in families

Today, Golden Helix, Inc., a global leader in genetic analysis solutions, announced a collaboration with Harvard School of Public Health (HSPH) under which Golden Helix is refactoring PBAT, HSPH's software for studying disease heritability in families.

23 Sep 2010

Ultrasonix launches new SonixVCR diagnostic ultrasound imaging recording system

Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems is pleased to announce today the introduction of SonixVCR, a software-based innovation that records, stores, and exports entire exams in a standard digital format.

23 Sep 2010

SynCardia temporary Total Artificial Heart wins 2010 Kerrin Rennie Award

On Sept. 15, the SynCardia temporary Total Artificial Heart was awarded the 2010 Kerrin Rennie Award for Excellence in Medical Technology by the Medical Technology Association of Australia (MTAA).

23 Sep 2010

Abbott announces positive results of bioresorbable vascular device at TCT conference

Abbott today announced positive nine-month results from the first 45 patients enrolled in the second stage of the ABSORB trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same 45-patient group, with the rate of major adverse cardiac events (MACE) unchanged at 4.4 percent and no reports of blood clots (thromboses).

23 Sep 2010

LWW and Ovid enter collaboration with Joanna Briggs Institute

Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy, has announced an exclusive partnership with the Joanna Briggs Institute (JBI), a recognized global leader in evidence-based healthcare resources based at the University of Adelaide, Australia, as part of an expansion of the nursing, allied health, and medical content delivered to customers of products in the Lippincott Williams & Wilkins (LWW) journals and Ovid brands.

23 Sep 2010

NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Ambulatory EHR version 5.6, a CCHIT Certified® 2011 Ambulatory EHR, has been additionally certified for Dermatology and Behavioral Health in the Certification Commission for Health Information Technology's (CCHIT®) certification program.

23 Sep 2010

New iPhone application for breast cancer patients

Nonprofit Breastcancer.org has launched an iPhone application for breast cancer patients. The Breast Cancer Diagnosis Guide is a free mobile app that walks users through the breast cancer pathology report a vital report that sets the patient's treatment path.

23 Sep 2010

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.

23 Sep 2010